Page 8 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Axsm Today - Breaking & Trending Today

HC Wainwright Lowers Axsome Therapeutics (NASDAQ:AXSM) Price Target to $190.00

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price decreased by equities research analysts at HC Wainwright from $200.00 to $190.00 in a research report issued to clients and investors on Monday, FlyOnTheWall reports. HC Wainwright’s price objective indicates a potential upside of 156.17% from the stock’s current price. AXSM has been the […] ....

United States , Morgan Stanley , Axsome Therapeutics Inc , Vanguard Group Inc , Axsome Therapeutics , Get Free Report , State Street Corp , Street Corp , Axsome Therapeutics Daily , Nasdaq Axsm , Lower Price Target , Hc Wainwright ,

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 2.5%

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report)’s share price rose 2.5% during mid-day trading on Thursday . The stock traded as high as $74.64 and last traded at $74.57. Approximately 480,521 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 926,140 shares. The stock had previously closed at […] ....

United States , Axsome Therapeutics Inc , Jpmorgan Chase Co , Sei Investments Co , Morgan Stanley , Raymond James Financial Services Advisors Inc , Axsome Therapeutics Company Profile , Metlife Investment Management , Panagora Asset Management Inc , Axsome Therapeutics , Free Report , James Financial Services Advisors , Life Investment Management , Asset Management , Sei Investments , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been given an average recommendation of “Moderate Buy” by the thirteen ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and ten have assigned a buy recommendation to the […] ....

United States , Tower Research Capital , China Universal Asset Management Co , Armstrong Advisory Group Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Morgan Stanley , Axsome Therapeutics , Get Rating , Financial Advisors , Advisory Group , Universal Asset Management , Research Capital , Dark Forest Capital Management , Therapeutics Trading Down , Axsome Therapeutics Daily , Nasdaq Axsm ,